Table 1 Patient characteristics of the study population
From: The impact of frailty on survival in elderly intensive care patients with COVID-19: the COVIP study
All patients | Fit (CFS 1–3) | Vulnerable (CFS: 4) | Frail (CFS: 5–9) | |
|---|---|---|---|---|
n = 1346 | n = 874 | n = 193 | n = 279 | |
Female sex | ||||
n (%) | 381 (28) | 209 (24) | 64 (34) | 108 (39) |
Age | ||||
Median (IQR) | 75 (72–78) | 74 (72–77) | 76 (73–79) | 78 (74–82) |
Frailty score—CFS | ||||
Median (IQR) | 3 (2–4) | 2 (2–3) | 4 (4–4) | 6 (5–7) |
SOFA score | ||||
Median (IQR) | 6 (3–8) | 5 (3–8) | 6 (3–8) | 6 (4–9) |
BMI | ||||
Median (IQR) | 28 (25–31) | 27 (25–30) | 28 (25–31) | 28 (24–31) |
PaO2/FiO2 (mmHg), n (%) | ||||
≤ 100 | 485 (37) | 319 (37) | 65 (35) | 101 (37) |
> 100–200 | 546 (41) | 376 (43) | 76 (40) | 94 (34) |
> 200–300 | 173 (13) | 111 (13) | 25 (13) | 37 (13) |
> 300 | 125 (9) | 59 (7) | 11 (12) | 44 (16) |
Comorbidities, n (%) | ||||
Diabetes mellitus | 471 (35) | 240 (27) | 89 (47) | 142 (51) |
Ischemic heart disease | 291 (22) | 127 (14) | 59 (31) | 105 (39) |
Chronic renal insufficiency | 211 (16) | 77 (9) | 31 (17) | 103 (38) |
Arterial Hypertension | 896 (67) | 529 (61) | 139 (73) | 228 (82) |
Pulmonary disease | 314 (24) | 169 (20) | 60 (32) | 85 (31) |
Chronic heart failure | 205 (15) | 72 (6) | 49 (26) | 84 (32) |